FLT3-Mutated AML: Progress, Challenges, and Future Directions | Leticia Campoverde, MD

Leticia Campoverde, MD
Hematology Oncology Fellow
MD Anderson

Dr. Leticia Campoverde is a third-year Hematology–Oncology Fellow at MD Anderson Cancer Center. Originally from Quito, Ecuador, she completed medical school at Universidad San Francisco de Quito and Internal Medicine residency at the University of Miami. Her research interests include acute myeloid leukemia, mechanisms of therapeutic resistance, targeted therapies, and clinical outcomes research. Her long-term goal is to become an academic investigator focused on improving outcomes and developing more effective treatments for patients with hematologic malignancies. Dr. Campoverde received the 2026 ASCO Young Investigator Award for her work in FLT3-mutated AML and the 2023 ASCO Conquer Cancer Merit Award for her research in precision oncology.

JOIN HERE!

Dr. Lunning’s objectives:

• Analyze the biologic and clinical significance of FLT3 mutations in AML
• Analyze the evolution of FLT3-targeted therapies
• Examine mechanisms of resistance

Faculty Disclosure

Dr. Campoverde does not have relevant financial relationships with ineligible companies.

Planning Committee Disclosure

Dr. Lekakis has indicated that he has no relevant financial relationships with commercial interests.

Target Audience

Faculty, Primary Care Physicians, APRNs, PharmD

Accreditation

The University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.